Home/Filings/4/0001643074-16-000005
4//SEC Filing

Axovant Sciences Ltd. 4

Accession 0001643074-16-000005

CIK 0001636050operating

Filed

May 2, 8:00 PM ET

Accepted

May 3, 12:02 PM ET

Size

6.0 KB

Accession

0001643074-16-000005

Insider Transaction Report

Form 4
Period: 2016-04-29
Altmeyer Mark
Pres&Chief Commercial Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2016-04-29+75,00075,000 total
    Exercise: $13.00Exp: 2026-04-29Common Shares (75,000 underlying)
Footnotes (2)
  • [F1]This option vests over a period of four years, with one quarter of the common shares underlying the option vesting on April 29, 2017 and the remainder vesting in twelve equal quarterly installments thereafter. The option allows for early exercise, subject to the Issuer's repurchase option with respect to any unvested common shares. All common shares underlying such option will become fully vested upon a change in control, as that term is defined in the Issuer's 2015 Equity Incentive Plan.
  • [F2]Includes only options with the same termination date.

Issuer

Axovant Sciences Ltd.

CIK 0001636050

Entity typeoperating

Related Parties

1
  • filerCIK 0001636050

Filing Metadata

Form type
4
Filed
May 2, 8:00 PM ET
Accepted
May 3, 12:02 PM ET
Size
6.0 KB